GAM Holding’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,044
| Closed | -$320K | – | 269 |
|
|
2022
Q2 | $320K | Hold |
3,044
| – | – | 0.02% | 226 |
|
|
2022
Q1 | $389K | Sell |
3,044
-2,773
| -48% | -$334K | 0.02% | 239 |
|
|
2021
Q4 | $717K | Hold |
5,817
| – | – | 0.03% | 209 |
|
|
2021
Q3 | $827K | Buy |
5,817
+2
| +0% | +$294 | 0.04% | 207 |
|
|
2021
Q2 | $908K | Buy |
+5,815
| New | +$942K | 0.04% | 233 |
|
|
2019
Q4 | – | Sell |
-19,355
| Closed | -$2.58M | – | 803 |
|
|
2019
Q3 | $2.58M | Hold |
19,355
| – | – | 0.11% | 203 |
|
|
2019
Q2 | $2.21M | Hold |
19,355
| – | – | 0.09% | 251 |
|
|
2019
Q1 | $2.4M | Buy |
19,355
+2,831
| +17% | +$322K | 0.1% | 227 |
|
|
2018
Q4 | $1.66M | Sell |
16,524
-10,403
| -39% | -$1.17M | 0.08% | 260 |
|
|
2018
Q3 | $3.44M | Buy |
26,927
+3,060
| +13% | +$364K | 0.13% | 188 |
|
|
2018
Q2 | $2.58M | Buy |
23,867
+1,930
| +9% | +$210K | 0.09% | 243 |
|
|
2018
Q1 | $2.32M | Sell |
21,937
-105
| -0.5% | -$12.2K | 0.08% | 258 |
|
|
2017
Q4 | $2.58M | Buy |
22,042
+10,886
| +98% | +$1.23M | 0.08% | 301 |
|
|
2017
Q3 | $1.27M | Sell |
11,156
-31,312
| -74% | -$3.61M | 0.05% | 323 |
|
|
2017
Q2 | $5.29M | Sell |
42,468
-8,620
| -17% | -$1.02M | 0.08% | 308 |
|
|
2017
Q1 | $6.06M | Buy |
51,088
+7,651
| +18% | +$867K | 0.1% | 255 |
|
|
2016
Q4 | $4.35M | Sell |
43,437
-3,554
| -8% | -$381K | 0.08% | 294 |
|
|
2016
Q3 | $5.93M | Buy |
46,991
+15,136
| +48% | +$1.87M | 0.1% | 225 |
|
|
2016
Q2 | $3.72M | Buy |
31,855
+3,798
| +14% | +$430K | 0.06% | 362 |
|
|
2016
Q1 | $2.9M | Buy |
28,057
+1,372
| +5% | +$133K | 0.05% | 385 |
|
|
2015
Q4 | $2.66M | Sell |
26,685
-27,253
| -51% | -$2.67M | 0.04% | 426 |
|
|
2015
Q3 | $4.92M | Sell |
53,938
-1,266
| -2% | -$127K | 0.08% | 259 |
|
|
2015
Q2 | $5.85M | Sell |
55,204
-577
| -1% | -$63.8K | 0.08% | 264 |
|
|
2015
Q1 | $6.37M | Buy |
55,781
+2,561
| +5% | +$292K | 0.1% | 249 |
|
|
2014
Q4 | $5.86M | Sell |
53,220
-1,659
| -3% | -$175K | 0.09% | 256 |
|
|
2014
Q3 | $5.36M | Sell |
54,879
-5,332
| -9% | -$524K | 0.08% | 279 |
|
|
2014
Q2 | $6.07M | Sell |
60,211
-13,874
| -19% | -$1.35M | 0.09% | 246 |
|
|
2014
Q1 | $6.8M | Buy |
74,085
+32,123
| +77% | +$2.96M | 0.11% | 221 |
|
|
2013
Q4 | $3.8M | Sell |
41,962
-4,161
| -9% | -$360K | 0.07% | 319 |
|
|
2013
Q3 | $3.68M | Sell |
46,123
-19,560
| -30% | -$1.54M | 0.07% | 330 |
|
|
2013
Q2 | $4.78M | Buy |
+65,683
| New | +$4.91M | 0.1% | 233 |
|
Other funds holding ZBH
GAM Holding's ZBH Position: Q3 2022 in Review
GAM Holding sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 3,044 shares — an estimated $320K sold.
GAM Holding first reported a position in ZBH in Q2 2013 and held it in 31 quarters. The position peaked at $6.8M in Q1 2014. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.
- GAM Holding reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
- GAM Holding sold 3,044 Zimmer Biomet shares in Q3 2022, an estimated $320K.
- GAM Holding first reported a position in Zimmer Biomet in Q2 2013 and held it in 31 quarters.
- GAM Holding's Zimmer Biomet position peaked at $6.8M in Q1 2014.
- 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.
Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.